View Older Stories View More Recent Stories
-
Tetraphase Pharma (TTPH) Climbs 17% Following BMO Capital Upgrade to Outperform
-
New Gold Closes US$173 Million Bought Deal Financing
-
BMO Capital Downgrades Winnebago Industries (WGO) to Outperform
-
BMO Capital Reiterates Outperform Rating and $295 PT on Ulta Salon (ULTA) Following 4Q EPS Beat; ' Many Positives'
-
BMO Capital Upgrades Tetraphase Pharmaceuticals (TTPH) to Outperform
-
Monmouth Real Estate Investment Corporation Announces Closing of Preferred Stock Offering
-
AIG (AIG) CEO Resignation 'A Positive for the Stock'; Reiterate Outperform and $70 PT - BMO Capital
-
Mitel Announces Closing of New Credit Facility
-
e.l.f. Beauty (ELF) PT Raised to $38 at BMO Capital on Strong 4Q EPS Beat; 'Higher Conviction in Upside'
-
BMO Capital Upgrades Greif Inc. (GEF) to Market Perform
-
BMO Capital Reiterates Outperform Rating and $30 PT on Ciena (CIEN); 'Many Demand Drivers, Buyers on Weakness'
-
Casey's General Stores (CASY) PT Lowered to $108 at BMO Capital; 'Lowering Merchandise Sales and Margin Forecasts'
-
Gibsons Commences Cash Tender Offers for Outstanding Canadian Dollar Notes due 2020 and U.S. Dollar Notes due 2021
-
Rigel Pharma (RIGL) Reiterates Outperform Rating and $4 PT on Rigel Pharma (RIGL); 'Focused on Fostamatinib's Pending NDA Submission'
-
JBT Corp. (JBT) Prices 2M Share Offering at $85
-
John Bean Technologies Corporation Prices Public Offering of Common Stock
-
Arch Coal, Inc. Announces Successful Closing of $300 Million Senior Secured Term Loan Facility
-
BMO Financial Group rings the NYSE Opening Bell to mark its 200 years in business
-
BMO Capital Downgrades Nimble Storage (NMBL) to Market Perform Amid Takeover
-
NVIDIA (NVDA): Sticking with Underperform - BMO
-
General Motors (GM): Good Value Creation Focus But Not a Meaningful Transaction - BMO
-
BMO Capital Maintains Outperform Rating and $45 PT on Hain Celestial (HAIN); 'Risk-Reward Looks Favorable'
-
BMO Capital Maintains Market Perform Rating and $78 PT on Vertex Pharma (VRTX) Following Concert CTP-656 Acquisition
-
Ionis Pharmaceuticals (IONS) PT Lowered to $59 at BMO Capital on Volanesorsen Data; 'Compliance Rate to 75% from 85%'
-
Ra Pharma (RARX) PT Raised to $31 at BMO Capital on Positive RA101495 Expectations
-
Monmouth Real Estate Investment Corporation Announces Pricing Of Preferred Stock Offering
-
JBT Corp. (JBT) to Offer 2M Common Shares
-
John Bean Technologies Corporation Announces Public Offering of 2,000,000 Shares of Common Stock
-
TELUS closes US and Canadian debt offerings
-
Monmouth Real Estate Investment Corporation Announces Public Offering of Preferred Stock
-
Lumina Gold Announces Appointment of VP Corporate Development and Communications
-
Anfield Gold Announces Appointment of VP Corporate Development and Communications
-
Global Medical REIT Inc. Announces Significant Expansion of Revolving Credit Facility
-
Norwest Equity Partners Commits Investment Capital to Twin Cities-Based Business Services Leader Bailiwick
-
BMO Capital Maintains Outperform Rating and $212 PT on Amgen (AMGN) Following Endeavor Phase 3 Data Presentation
-
BMO Capital Maintains Outperform Rating and $180 PT on Costco Wholesale (COST); Model Benefits from Catalysts
-
BMO Capital Upgrades FedEx (FDX) to Outperform
-
BMO Capital Remains Bullish On Apple (AAPL) iPhone Installed Base
-
Rubicon Minerals Announces the Closing of the C$10.0 Million Flow-Through Financing
-
Resolute Energy (REN) to Acquire Assets in Delaware Basin for $160M
-
Resolute Energy Corporation Announces $160 Million Delaware Basin Acquisition
-
BMO Capital Maintains Outperform Rating and $180 PT on Costco (COST) Following 'Large' FQ2 EPS Miss; 'Several Margin-Related Headwinds'
-
Kroger (KR) PT Lowered to $34 at BMO Capital Following Q4 Results; 'Underperforming Peers'
-
Financial 15 Split Corp. Completes Overnight Offering of $61,090,000
-
American Eagle Outfitters (AEO) PT Lowered to $18 at BMO Capital
-
Darling International (DAR) PT Raised to $19 at BMO Capital on 4Q EPS Beat, Biodiesel Tax Credit Optimism
-
Serabi Gold plc : Corporate Presentation
-
Retrophin (RTRX) PT Lowered to $45 at BMO Capital on Phase 3 Trial Initiation for Sparsentan; '75% Probability of Success'
-
Anglo Pacific Group PLC: Notice of Results: Full Year 2016 Results
-
Atalaya Mining PLC: Granting of share options

